Edition:
United Kingdom

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

16.87USD
16 Jan 2019
Change (% chg)

$-0.11 (-0.65%)
Prev Close
$16.98
Open
$16.98
Day's High
$17.61
Day's Low
$16.76
Volume
73,744
Avg. Vol
155,203
52-wk High
$34.98
52-wk Low
$12.56

Chart for

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: --
Market Cap(Mil.): $792.65
Shares Outstanding(Mil.): 36.87
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 69.71 34.38
EPS (TTM): -1.70 -- --
ROI: -26.13 8.99 14.96
ROE: -81.04 10.13 16.53

Earnings vs. Estimates